Prolotherapy for Knee Pain: Evidence, Protocols, and What to Expect

Knee pain is the single most common reason people seek out prolotherapy. And for good reason, the knee is a joint that takes an enormous beating over a lifetime, and conventional options for knee osteoarthritis often feel like a choice between “not enough” (physical therapy and anti-inflammatories) and “too much” (total knee replacement).

Prolotherapy occupies a middle ground that appeals to many patients: a relatively simple injection procedure that aims to stimulate the body’s own repair processes, potentially delaying or avoiding surgery. But does it actually work for knee pain? Let us look at what the evidence says, who responds best, and how prolotherapy for the knee compares to other injection therapies.

How Prolotherapy Works in the Knee

Prolotherapy, short for “proliferant therapy”, works by injecting an irritant solution (most commonly dextrose at 12.5-25% concentration) into damaged or degenerated tissues. In the knee, injections target multiple structures:

• Intra-articular space: Directly into the joint capsule to address cartilage degeneration and synovial inflammation
• Collateral ligaments: The medial collateral ligament (MCL) and lateral collateral ligament (LCL) at their attachment points
• Patellar tendon: At the tibial tuberosity and patellar attachments
• Surrounding entheses: Where tendons and ligaments attach to bone around the knee

The dextrose solution triggers a localized inflammatory cascade that recruits growth factors, fibroblasts, and other healing cells to the injection site. Over a period of weeks, this leads to collagen deposition, tissue strengthening, and in the case of intra-articular injections, potential improvement in the joint environment.

A typical knee prolotherapy session involves 10-20 individual injection points around the knee, covering both the intra-articular space and the periarticular soft tissues. This full approach distinguishes prolotherapy from single-injection therapies like cortisone or hyaluronic acid.

The Evidence: What Do the Studies Show?

Prolotherapy for knee osteoarthritis has one of the stronger evidence bases in the prolotherapy literature. Several key studies stand out:

The Rabago Trials

Dr. David Rabago and colleagues at the University of Wisconsin have conducted the most rigorous trials of dextrose prolotherapy for knee OA:

• Rabago et al. (2013), Annals of Family Medicine: A randomized controlled trial of 90 adults with knee OA compared dextrose prolotherapy to saline injections and at-home exercise. The prolotherapy group showed significantly greater improvements in WOMAC pain, function, and stiffness scores compared to both control groups at 52 weeks. Improvements were clinically meaningful and sustained.
• Rabago et al. (2012), complementary study: Demonstrated improvements in patient-reported knee-specific quality of life and overall function with dextrose prolotherapy.

Cochrane and Systematic Reviews

A systematic review and meta-analysis published in the Journal of Alternative and Complementary Medicine (2017) analyzed available RCTs and concluded that dextrose prolotherapy provided clinically meaningful improvements in pain, function, and stiffness for knee OA when compared to control interventions. The effect sizes were moderate, and the treatment was well-tolerated.

The Cochrane Collaboration has noted that while the evidence is promising, more large-scale, multi-center trials with longer follow-up are needed to establish prolotherapy as a standard treatment recommendation.

Key Findings Across Studies

Prolotherapy vs. Other Knee Injections

If your doctor has discussed injection options for your knee, you have probably heard about cortisone and hyaluronic acid (viscosupplementation). Here is how dextrose prolotherapy compares:

One of the most compelling arguments for prolotherapy over cortisone is the long-term safety profile. A landmark 2017 study in Radiology demonstrated that repeated corticosteroid injections were associated with accelerated cartilage loss in knee OA compared to saline injections. Prolotherapy, by contrast, aims to promote tissue repair rather than suppress it.

The Prolotherapy Protocol for Knee Pain

Here is what a typical prolotherapy treatment course for knee pain looks like:

Initial Evaluation

Your practitioner will review imaging (X-rays, possibly MRI), perform a physical examination assessing ligament stability, joint line tenderness, and range of motion, and take a detailed history of your knee symptoms. This evaluation determines the injection strategy and sets realistic expectations.

The Injection Session

• Solution: Most commonly 12.5-25% dextrose (higher concentrations for intra-articular, lower for periarticular structures)
• Volume: 30-60 mL total across all injection points
• Injection sites: 10-20 points including the joint space, medial and lateral collateral ligaments, patellar tendon attachments, and pes anserinus
• Guidance: Some practitioners use ultrasound guidance for intra-articular injections; periarticular injections are typically done by palpation
• Duration: 15-30 minutes for the injection procedure itself
• Anesthesia: Typically includes lidocaine mixed with the dextrose solution; some practitioners use a separate local anesthetic

Treatment Course

• Number of sessions: 4-6 sessions for most patients; some need up to 8
• Spacing: Every 3-6 weeks between sessions
• Total duration: 3-9 months to complete treatment
• Response assessment: Most practitioners evaluate progress after 3 sessions to determine whether to continue

Post-Injection

• Expect increased pain and swelling for 2-5 days after each session, this is the intended inflammatory response
• Avoid NSAIDs (ibuprofen, naproxen) for 2-3 days after treatment, as they counteract the therapeutic inflammation
• Acetaminophen (Tylenol) is permitted for pain management
• Light activity is encouraged; avoid heavy exercise for 3-5 days
• Ice is typically discouraged in the first 24-48 hours (to allow the inflammatory response); some practitioners allow it after that

Who Responds Best to Knee Prolotherapy?

Not everyone with knee pain is a good candidate for prolotherapy. Based on the evidence and clinical experience, the best responders tend to be:

• Mild-to-moderate knee OA (Kellgren-Lawrence grade 1-3), there is still functional cartilage and joint space remaining
• Ligament laxity or instability, the knee “gives way” or feels unstable, particularly with MCL or LCL involvement
• Younger patients (under 65) who want to delay or avoid joint replacement
• Active individuals whose pain limits function but who are otherwise healthy
• Patients who have failed physical therapy and bracing but are not ready for surgery
• Those willing to commit to the full 4-6 session course rather than expecting one-injection results

When NOT to Use Prolotherapy for the Knee

Prolotherapy is unlikely to be effective and may not be appropriate in these situations:

• Severe bone-on-bone OA (Kellgren-Lawrence grade 4): When there is no remaining joint space and bone is articulating directly with bone, prolotherapy cannot regenerate sufficient cartilage to restore joint function. Joint replacement is typically the appropriate intervention at this stage.
• Acute meniscal tears requiring surgical repair: A locked knee from a bucket-handle meniscal tear needs arthroscopic surgery, not injection therapy.
• Active joint infection: Injecting into an infected joint is contraindicated.
• Inflammatory arthritis (active RA, gout flare): The underlying disease process requires systemic treatment, not local injection.
• Unrealistic expectations: Prolotherapy aims to improve pain and function by 30-50% in most responders, it does not restore the knee to its 20-year-old state.

Frequently Asked Questions

How painful are prolotherapy injections in the knee?

Most patients describe the injections as moderately uncomfortable rather than severely painful. The intra-articular injection typically causes a feeling of pressure and achiness, while periarticular injections at ligament attachments can produce a brief, sharp sensation at each injection point. The lidocaine mixed into the solution provides some immediate pain relief. Most patients tolerate the procedure well and return to normal activities within a few days, though the knee will be sore and swollen for 2-5 days after each session.

Can prolotherapy regrow knee cartilage?

This is a common claim that requires careful qualification. There is limited evidence from animal studies and small human studies suggesting that intra-articular dextrose may improve the joint environment and potentially slow cartilage degradation. However, there is no strong evidence that prolotherapy regenerates significant amounts of hyaline cartilage in humans. The clinical benefits likely come from improved ligament and tendon integrity, reduced pain signaling, and improved joint biomechanics rather than from cartilage regrowth per se.

Is prolotherapy covered by insurance for knee pain?

In the vast majority of cases, no. Most commercial insurance plans and Medicare consider prolotherapy experimental or investigational and do not cover it. Some practitioners offer superbills that patients can submit for potential partial reimbursement, but this is uncommon. The typical out-of-pocket cost for a full treatment course (4-6 sessions) ranges from $800 to $3,600 depending on the practitioner, geographic location, and whether ultrasound guidance is used.

How long do prolotherapy results last for knee pain?

In the Rabago RCT, improvements were sustained at the 52-week follow-up, and an observational extension suggested benefits persisting at 2.5 years. However, prolotherapy does not halt the underlying degenerative process permanently. Some patients return for maintenance sessions (1-2 per year) to sustain their results. Patients who combine prolotherapy with consistent exercise, weight management, and joint-protective strategies tend to have the longest-lasting benefits.

Related Reading

This article is part of our thorough guide to prolotherapy. For a broader overview of how prolotherapy works, what conditions it treats, and how to find a qualified practitioner, see our pillar article: Prolotherapy: The Complete Guide.